During the past decade, Instituto de Cardiologia do Distrito Federal conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Cardiologia do Distrito Federal" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Hospital do Coracao" with 2 trials sponsored, "Brasilia Heart Study Group" with 1 trials sponsored, "Hospital Israelita Albert Einstein" with 1 trials sponsored and "Hospital Sirio-Libanes" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Cardiologia do Distrito Federal" #1 collaborator was "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Hospital Israelita Albert Einstein" with 2 trials as a collaborator, "Ministry of Health, Brazil" with 2 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Cardiologia do Distrito Federal" are "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials) and "At Least 10 Points in Rassi Risk Score for Death" (1 trials). Many other conditions were trialed in "Instituto de Cardiologia do Distrito Federal" in a lesser frequency.

Most popular intervention types in "Instituto de Cardiologia do Distrito Federal" are "Drug" (10 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Clopidogrel" (1 trials), "Dexamethasone" (1 trials) and "Double Dose Quadrivalent Influenza Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Cardiologia do Distrito Federal" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Cardiologia do Distrito Federal". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Instituto de Cardiologia do Distrito Federal, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Cardiologia do Distrito Federal, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".